Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Sigma A6730 | 3.0 | uM | 3 | IL-17 | 48.5 | 66 | ||||
N2586 | IL-6 | 100 | ug/mL | 3 | IL-17 | 45.0 | 76 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | IL-17 | 45.0 | 69 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-17 | 47.0 | 74 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-17 | 47.0 | 50 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-17 | 46.0 | 71 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | IL-17 | 49.0 | 79 | |
N2586 | Sigma A6730 | 3.0 | uM | 3 | IL-17 | 45.0 | 65 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 65.0 | 58 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 59.0 | 68 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 51.0 | 65 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 67.0 | 60 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 65.5 | 74 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 45.0 | 61 | |
RA2159 | PI103 | 0.1 | uM | 3 | IL-17 | 45.5 | 46 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 64.5 | 72 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 60.0 | 65 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 63.0 | 78 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 64.0 | 48 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 53.0 | 49 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 55.5 | 60 | |
N2586 | PI103 | 0.1 | uM | 3 | IL-17 | 39.0 | 65 | ||||
0 | IL-17 | 51.0 | 61 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 3 | IL-17 | 71.0 | 51 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | IL-17 | 67.5 | 46 |